CX3CL1 and colon carcinoma: Indeed, high serum concentrations of soluble CX3CL1 were associated with low T cell cytotoxicity while low serum concentrations of soluble CX3CL1 were associated with high T cell cytotoxicity at the tumor site in a mouse model of adoptive T cell therapy of colon carcinoma (73).